Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech)

精蛋白重组人胰岛素注射液（深圳科兴）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIsophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech)
Drug Alias Name苏泌啉恩
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2003/02/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Kexing Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Kexing Biological Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A